Oil Breaking Out, But The Money Is Elsewhere
One resource industry dwarfs the rest of them put together: energy. The mega-shift of the 21st century is urbanization. For the first time in human history, more people live in cities than in rural areas. The consequences of this pivotal moment are attracting billionaire moguls across the globe, and they are all looking for a […]
McDonald’s Garners PR Bonanza With Unauthorized Rick And Morty Szechuan Sauce Promotion
McDonald’s Corporation (MCD) develops, operates, franchises and services a worldwide system of restaurants that prepare, assemble, package and sell a limited menu of value-priced foods. The company operates primarily in the quick-service hamburger restaurant business. All restaurants are operated by the company or, under the terms of franchise arrangements, by franchisees who are independent third […]
Maturity Creep – A Key Trend For Global Bond Investors
I was looking through some statistics on the global government bond markets, specifically the Thomson Reuters Government Bond Indexes. A couple of key metrics and trends struck me as a big shift in the risk and return make up of global government bond markets has taken place. The chart of interest comes from my latest weekly […]
HeadlineCharts – Monday, October 9th
Is the market finally ready to roll over short-term? The bullish percents look ready for a change of direction… or at least a pause. The net advance/decline line could be pausing too. There is usually a very strong correlation between EEM and CEW which is an ETF containing Emerging Market currencies. My guess […]
Clovis Oncology Submits Supplemental New Drug Application For Rucaparib
BOULDER, Colo.–(BUSINESS WIRE)–Clovis Oncology (NASDAQ: CLVS) announced today that the company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for rucaparib as maintenance treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. […]
Buying Stocks Below Their Cash Value
Do you think a return of 56% over a period of less than two years is pretty good? How about 115%? Those are the actual returns of stocks that you could have bought less than two years ago that were selling for less than the cash per share. What is cash per share? In simple […]
A Beginner’s Guide To Part Time Real Estate Investing
Wondering how to boost your investing game while you work a full-time job? Curious if efforts spent on part time real estate investing will help you see the career gains you desire? Looking to get a crash course on “real estate investing for beginners” while you get a paycheck from somebody else? There are many […]
Scenes From The September Jobs Report
On Friday I highlighted the difference between the results of the establishment survey and the household survey. A 2006 paper from the BLS (pdf) explaining the differences in how jobs are counted in the two surveys shows us why: Interviewers from the Census Bureau contact households and ask questions regarding the labor force status of […]
Is Market Breadth Confirming The Stock Market’s Recent Highs?
Volume-Based Breadth Indicator The monthly chart below shows the NYSE’s volume associated with advancing issues minus volume associated with declining issues. As of October 9, 2017, the indicator has been making new highs along with the market. Fact or Fiction? This week’s stock market video water tests three widely held beliefs about bull and bear […]
Avon Lacks Luster: Can Transformation Plan Aid Turnaround?
Avon Products, Inc (AVP – Free Report) has been out of investors’ favor for quite some time now. The company’s persistent dismal performance can be attributed to weak Active Representatives. Reflecting the struggles of this beauty products retailer, recent records reveal that it has missed earnings and sales estimates for four consecutive quarters now. Evidently, […]
